FDA-Yakagamuchirwa Kwechimwe CheSpondyloarthropathie uye Plaque Psoriasis
Cosentyx (secukinumab), yakaitwa naNovartis, yakagamuchirwa neDFA musi waJanuary 15, 2016 pakurapa kwevanhu vakuru vane chekuita ankylosing spondylitis uye inoshanda psoriatic arthritis . Yakanga yatove yakagamuchirwa munaJanuary 2015 kuti ienzanise kusvika kune yakawanda mapikori psoriasis kune vanhu vakuru vanozvigadzirira kurapwa kwemaitiro kana phototherapy. Ankylosing spondylitis uye psoriatic arthritis ndezvokuvhiringidza mararamiro anonzi arthritis anotsanangurwa sepondyloarthropathies .
Kubvumirwa kweCosentyx kune ankylosing spondylitis uye psoriatic arthritis kwakabva kune zvakabuda kune maviri ankylosing spondylitis uye maviri psoriatic arthritis placebo-yakarongwa chikamu III kliniki miedzo yakaongorora kuchengetedza uye kubudirira. Miedzo yaisanganisira vanhu vanopfuura 1 500 vakanga vane imwe yemamiriro maviri aya.
Chii Chinonyanya Kuitika?
Cosentyx mishonga inoshanda mumuviri wechirwere chekuzvidzivirira kuti itarame zvirwere zvataurwa nezvataurwa. Kunyanya, Cosmostx munhu anonzi interleukin-17A anopikisa (IL-17A) -a monoclonal antibody anonamatira kuI-ILA uye anovhara kusangana nemusangano we IL-17. Ndiyo mutambi wekutanga interleukin-17A anobvumirwa kupata ankylosing spondylitis, psoriatic arthritis, uye plaque psoriasis.
Mishonga Inotarisirwa Sei?
Cosentyx inotungamirirwa nejasi remajekiti mumakumbo makuru kana mudumbu. Cosentyx inowanikwa senjodzi inogadziriswa (150 mg / mL) mune imwe shandisa Sensoready pen.
Inowanikwawo mune imwechete-shanduro inoshandiswa syringe (150 mg / mL). Pane chigadziko chinofanira kuyananiswa, zvakare, asi icho chiri chevashandi vehutano chete.
Kune vanhu vane active psoriatic arthritis kana ankylosing spondylitis, chirongwa chinokurudzirwa cheCosentyx chinosanganisira kukosha chirwere che 150 mg pamasvondo 0, 1, 2, 3 uye 4, inoteverwa nemasvondo mana.
Inogonawo kugoverwa mavhiki mana musina teji yekudira. Kana chirwere icho chikaramba chichishanda, chirwere che 300 mg chinogona kufungwa. Nokuda kweporioriasis, iyo inorayirwa mazai 300 mg pamasvondo 0, 1, 2, 3, 4 uye masvondo mana mushure mazvo. Muto wepasi we 150 mg ungave wakakwana kune vamwe vanhu. Kune vanhu vane psoriatic arthritis uye plaque psoriasis, iyo protocol for plaque psoriasis inokurudzirwa.
Ndiani Asingafaniri Kushandisa Cosentyx?
Vanhu avo vane chirwere chakanyanya kufanana neeeckinkinumab havafaniri kushandisa mishonga.
Nharaunda Dzakabatana
Matambudziko anowanzobatanidzwa neConentyx anosanganisira nasopharyngitis (zviratidzo zvinotonhora), kuputika kwepamusoro, uye chirwere. Dzimwe mimwe migumisiro inobvira uye kana iwe uchinge uchinetseka chipi nechipi chekufunganya, taura nachiremba wako.
Manyevero uye Kuchengetedza
Zvimwe nyevero nezvinochengetedzwa zvinobatanidzwa neCosentyx:
- Zvirwere zvakakomba zvakaitika nekushandiswa kwayo. Nekuda kweCexentyx kune maitiro ezvirwere zvemuviri, zvinogona kuderedza kukwanisa kwako kurwisa zvirwere uye zvinogona kuwedzera ngozi yako yezvirwere. Kana chirwere chakakomba chinowedzera paunenge uchishandisa Cosentyx, rega kushandiswa kwemishonga apo hutachiona hunotapwa. Kutaura zvazviri, vanhu vane hutachiwana hwehutachiwana, hutachiona hwehutachiona, kana nhoroondo yezvirwere zvinowanzoitika dzinofanira kungwarira uye kukurukura nhoroondo yavo yehutachiona nechiremba wavo vasati vashandisa Cosentyx.
- Usati watanga kurapwa neCosentyx, unofanira kutarirwa nehutachiona . Kana chiremba wako achifunga kuti uri pangozi yehutachiwana nokuti wakambove wakaratidzwa, unogona kurapwa neTBT usati watanga Cosentyx uye apo iwe unobatwa neCosentyx.
- Mumakiriniki ekuedzwa, zvirwere zvitsva zvezvipembenene zvezvirwere zvakaonekwa, pamwe nekuwedzera kwevaya vane IBD. Kuchenjerera kunofanira kushandiswa apo Cosestx inorayirwa kune mumwe munhu anonzi IBD.
- Anaphylactic kana zvakakomba zvinogadziriswa zvinogoneka. Kana ikaitika, Cosentyx inofanira kubviswa pakarepo uye iwe unofanira kutsvaga rubatsiro rwechiremba.
- Kurarisa zvirwere hazvifaniri kupiwa kwauri, kana ukashandisa Cosentyx.
- Pakave pasina dzidzo dzakakwana dzeCosentyx muvakadzi vane pamuviri. Izvowo hazvizivikanwe kana Cosentyx yakanyanyiswa mumukaka wemunhu kana inogadziriswa nenzira yakagadzirwa mushure mekudya. Kuchenjerera kunofanira kushandiswa.
Shoko Rinobva
Sezvatinoziva, zvinodhaka hazvifananidzi zvakafanana kune vose vanoedza. Ndicho chikonzero nei zvichikosha kuti uve nemaitiro akawanda emishonga. Kubvira kuCosentyx ndiyo mishonga yokutanga inotarisa interleukin-17A, nzira yekurapa inowanikwa ikozvino yakanga isina kuwanikwa musati mvumo yemishonga.
Kuti ushandise Cosdenx zvakachengeteka, unofanira kudzidza kudzima zvakanaka, zive kuti zvingava nemigumisiro uye zvinyevero, uye ugozivisa zviitiko zvinoshungurudza kana zvikaitika. Kana iwe uchida kudzidza zvakawanda pamusoro pechisarudzo ichi, chiendese icho kumushandi wako wehutano. Iye achakufambisa kusvika kune chisarudzo chakanaka kwauri.
Sources:
Cosentyx. Kunyora Mashoko . Novartis Pharmaceuticals Corporation. Yakarongwa munaJanuary 2016.
Cosentyx. Mishonga Gwaro . Novartis Pharmaceuticals Corporation. Yakarongwa munaJanuary 2016.